1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
(
- Contribution to journal › Article
-
Mark
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
(
- Contribution to journal › Scientific review
-
Mark
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study
(
- Contribution to journal › Published meeting abstract
-
Mark
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial
(
- Contribution to journal › Article
- 2015
-
Mark
An international study to increase concordance in Ki67 scoring.
(
- Contribution to journal › Article
- 2014
-
Mark
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
(
- Contribution to journal › Article